
Education and Training
- Surgeon-in-Chief, Ucsf Helen Diller Family Cancer Center, University of California San Francisco, School of Medicine, 2009 - 2011
- Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 2009 - 2011
- Chief, Division Of Breast Surgery Oncology, University of California San Francisco, School of Medicine, 2008 - 2011
- Associate Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 2004 - 2009
- Assistant Professor in Residence, Surgery, University of California San Francisco, School of Medicine, 1998 - 2004
- Senior Reigstrar, General Surgical Oncology, Singapore General Hospital (Singapore), 1998 - 1999
- Fellow, Breast Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 1996 - 1997
- Resident, General Surgery, Cornell University, 1992 - 1996
- Intern, General Surgery, Kaiser Foundation Hospital, 1991 - 1992
- M.P.H., University of California - Berkeley, 2006
- M.D., University of California - Los Angeles, 1991
In the News
- Duke Adds 21 Faculty to Distinguished Faculty RankMay 7, 2019
- Tar Heel of the Week: Duke cancer surgeon champions fewer mastectomiesMay 31, 2016
- The 100 Most Influential People: Surgery professor Shelley HwangApril 22, 2016
- Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016April 22, 2016
- Dr. Shelley Hwang: New measure of mastectomyMarch 22, 2016
- Double mastectomy may not be the answer for cancer in one breastMarch 18, 2016
- Quality of Life Not Notably Better for Women Choosing Double MastectomyMarch 8, 2016
- How elective breast cancer surgery affects quality of lifeMarch 8, 2016
- Biden seeks input for cancer 'moonshot' at Duke UniversityFebruary 11, 2016
- Study Aims to Resolve How To Manage Pre-Cancers of the BreastFebruary 4, 2016
- What's the Best Way to Treat Women with Stage 0 Breast Cancer?December 29, 2015
- Who can delay breast cancer treatment? A new math model adds cluesDecember 17, 2015
- With early breast cancer treatment, less may be more: StudiesDecember 10, 2015
- Why Aren't Cancer Death Rates for DCIS Falling?October 9, 2015
- Why Doctors Are Rethinking Breast Cancer TreatmentOctober 6, 2015
- Study: Chemo unnecessary in many cases of early-stage breast cancerOctober 5, 2015
- Dr. Shelley Hwang: Why doctors are rethinking breast-cancer treatmentOctober 1, 2015
- Some cancer experts see 'overdiagnosis,' question emphasis on early detectionSeptember 16, 2014
- Think pink: Lumpectomy vs. mastectomyOctober 4, 2013
Selected Grants
- Point-of-care cellular and molecular pathology of breast tumors on a cell phone
- NCI National Clinical Trials Network (UG1)
- Lumicell - PIVOTAL STUDY OF THE LUM IMAGING SYSTEM
- Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities
- Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS
- Breast Pre-Cancer Atlas Center
- Building Interdisciplinary Research Careers in Women's Health
- TBCRC 034: The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed with Intraductal Papilloma without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Genomic Diversity and the Microenvironment as Drivers of Progression in DCIS
- Translational Research in Surgical Oncology
- Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer
- Preoperative Breast Radiotherapy: A Tool to Provide Individualized and Biologically-Based Radiation Therapy
- Tissue tension, RANK and Breast Cancer Risk
- Comparing the Effectiveness of Guideline-concordant Care to Active Surveillance for DCIS: an Observational Study
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Targeting DAMP-induced inflammation to prevent metastasis
- Characterization of Tumor Immunobiological Factors that Promote Lymphovascular Invasion and Dissemination in Locally Advanced Breast Cancer
- Feasibility study phase C: Expansion into multiple institutions for training in the use of the LUM imaging system for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
- Prevent Ductal Carcinoma in Situ Invasive Overtreatment Now - PRECISION
- To estimate the mean change in MRI tumor volume from pretreatment to completion of preoperative endocrine therapy in ER(+) DCIS, as well as to determine whether 3-month change in volume correlates with 6-month change.
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Cancer Prevention Agent Development Program: Early Phase Clinical Research - CR
- (PQC3) Genomic Diversity and the Microenvironment as Drivers of Metastasis in DCIS
- NCI National Clinical Trials Network U10 (Year 5)
- Genetic testing for women with high-risk breast lesions
- Molecular and Radiologic Predictors of Invasion in a DCIS Active Surveillance Cohort
- Cancer Prevention Agent Development Program: Early Phase Clinical Research - FP
- The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
- Impact of the Oncotype DX DCIS Score on Treatment Decision Making in Patients with Ductal Carcinoma in Situ
- Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)
- Optimizing Parameters and Techniques in Circulation Tumor Cell Collection (OPTICOLL)